Structure Therapeutics
(NASDAQ:GPCR)
$36.15
0.37[1.03%]
At close: May 21
$36.15
0[0.00%]
After Hours: 7:59PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Structure Therapeutics Stock (NASDAQ:GPCR), Quotes and News Summary

Structure Therapeutics Stock (NASDAQ: GPCR) stock price, news, charts, stock research, profile.

Open$37.480
Close$35.810
Volume / Avg.535.293K / 584.983K
Day Range35.080 - 37.661
52 Wk Range22.100 - 75.017
Market Cap$1.685B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
41
Short Interest
11.4%
Days to Cover9.46

Recent News

Nasdaq Gains 100 Points; Biomerica Shares Spike Higher
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.01% to 37,307.40 while the NASDAQ rose 0.71% to 14,919.07. The S&P 500 also rose, gaining, 0.54% to 4,744.58.
Avi Kapoor
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic castration-resistant prostate cancer.
Avi Kapoor
Crude Oil Rises 3%; US Housing Market Index Increases In December
U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 50 points on Monday. The Dow traded up 0.14% to 37,356.29 while the NASDAQ rose 0.25% to 14,851.19. The S&P 500 also rose, gaining, 0.37% to 4,736.45.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Mar
2
Apr
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GPCR
SUPN

FAQ

Q

How do I buy Structure Therapeutics (GPCR) stock?

A

You can purchase shares of Structure Therapeutics (NASDAQ: GPCR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Structure Therapeutics's (GPCR) competitors?

A

Other companies in Structure Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), Verona Pharma (NASDAQ:VRNA), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).

Q

What is the target price for Structure Therapeutics (GPCR) stock?

A

The latest price target for Structure Therapeutics (NASDAQ: GPCR) was reported by JP Morgan on Tuesday, May 21, 2024. The analyst firm set a price target for 65.00 expecting GPCR to rise to within 12 months (a possible 79.81% upside). 14 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Structure Therapeutics (GPCR)?

A

The stock price for Structure Therapeutics (NASDAQ: GPCR) is $36.15 last updated May 21, 2024 at 7:59 PM EDT.

Q

Does Structure Therapeutics (GPCR) pay a dividend?

A

There are no upcoming dividends for Structure Therapeutics.

Q

When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?

A

Structure Therapeutics’s Q2 earnings are confirmed for Wednesday, August 14, 2024.

Q

Is Structure Therapeutics (GPCR) going to split?

A

There is no upcoming split for Structure Therapeutics.

Q

What sector and industry does Structure Therapeutics (GPCR) operate in?

A

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch